(Q38542168)

English

Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'.

scientific article published on 02 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

0 references

1 reference

Europe PubMed Central

Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giuseppe Losurdo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Mariabeatrice Principi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

G Leandro

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

F Giorgio

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

L Montenegro

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

C Sorrentino

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

publication date

2 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

International Journal of Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

69

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1112-1120

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26138290%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Diagnosis and epidemiology of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Helicobacter pylori and nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Extragastric diseases and Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

High eradication rates of Helicobacter pylori with a new sequential treatment

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Helicobacter pylori therapy: Present and future

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Clarithromycin-resistant genotypes and eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

The A2143G point mutation of clarithromycin resistance affects Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for clarithromycin resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Ornidazole-based sequential therapy is not effective in Helicobacter pylori eradication in children

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Virulence factors and antibiotic resistance in children with Helicobacter pylori gastritis.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Changing pattern of antibiotic resistance of Helicobacter pylori in children during 20 years in Jinju, South Korea.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Isolation of Helicobacter pylori in gastric mucosa and susceptibility to five antimicrobial drugs in Southern chile

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Comparison of E-test and disk diffusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Resistance to antibiotics and characterization of Helicobacter pylori strains isolated from antrum and body from adults in Mexico.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Current options for the treatment of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12687

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38542168&oldid=1645036811"